Cells were cultured at 37°C and 8% carbon dioxide with the media recommended by the manufacturer. The media were changed every other day and the cells were split enzymatically with Trypsin: 1× phosphate-buffered saline (Ref. 14190–185; Gibco Life Technologies) and Tryple Express (Ref. 12604–013; Gibco-Life Technologies) for PT-2501 cells, and the Trypsin kit (PromoCell GmbH) for C-12974 cells. Cultures were trypsinized when the cells were approximately 90% confluent.
C 12974
C-12974 is a laboratory equipment product. It serves as a core function without further details on its intended use.
Lab products found in correlation
8 protocols using c 12974
Comparative Analysis of hMSC Cell Lines
Cells were cultured at 37°C and 8% carbon dioxide with the media recommended by the manufacturer. The media were changed every other day and the cells were split enzymatically with Trypsin: 1× phosphate-buffered saline (Ref. 14190–185; Gibco Life Technologies) and Tryple Express (Ref. 12604–013; Gibco-Life Technologies) for PT-2501 cells, and the Trypsin kit (PromoCell GmbH) for C-12974 cells. Cultures were trypsinized when the cells were approximately 90% confluent.
Cytocompatibility and Osteoinductive Potential of Biomaterials
Characterization of Immortalized and Primary MSCs
Mesenchymal Stromal Cell Differentiation
Osteoblast Differentiation with PFF-A
huBM-MSCs were fed with mesenchymal stem cell growth medium (C-28009, PromoCell) and incubated in an atmosphere of 5% CO2 at 37 °C. Following 100% confluence cells were induced by MSC osteogenic differentiation medium (C-28013, PromoCell) and incubated until the time of analysis. PFF-A was introduced with differentiation medium and included in all medium changes (every third day).
Osteogenic Differentiation of MSPCs
Culturing Human Bone-Marrow Mesenchymal Stem Cells
Bone Healing Potential of Composite Implants
Human mesenchymal stem cells (hMSC) were purchased from Merck (C-12974 from PromoCell GmbH, Heidelberg, Germany, distributed by Merck, Milan, Italy) and cultivated in low-glucose Dulbecco’s modified Eagle Medium (DMEM, Merck) supplemented with 15% fetal bovine serum (FBS, Merck) and 1% antibiotics (penicillin/streptomycin, Merck) at 37 °C, 5% CO2 atmosphere. Human primary osteoblasts progenitors (hFOB 1.19 CRL-11372) were purchased from the American Type Culture Collection (ATCC, Manassas, VA, USA) and cultivated in MEM/F12 mix medium (50:50, from Sigma, Darmstadt, Germany) 10% fetal bovine serum (FBS, from Sigma) 1% antibiotics, and 3 mg/mL neomycin (G418 salt, Sigma) at 34 °C, 5% CO2 atmosphere. Human endothelial cells (EA.hy926, CRL-2922) were purchased from ATCC and cultivated in high-glucose Dulbecco’s modified Eagle Medium (DMEM, Sigma-Aldrich) supplemented with 10% fetal bovine serum (FBS, Sigma) and 1% antibiotics (penicillin/streptomycin) at 37 °C, 5% CO2 atmosphere. Cells were cultivated until 80–90% confluence, detached by trypsin-EDTA solution, harvested, and used for experiments.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!